A study of autologous dendritic cell therapy targeting mucin-1 for treatment of patients with epithelial ovarian cancer in first remission.
暂无分享,去创建一个
J. Berek | H. Gray | J. Fiorica | J. Mason | J. Goh
[1] E. Gilboa. DC-based cancer vaccines. , 2007, The Journal of clinical investigation.
[2] V. Apostolopoulos,et al. Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma , 2006, Clinical Cancer Research.
[3] V. Maino,et al. Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] V. Apostolopoulos,et al. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. , 1997, The Journal of clinical investigation.